Navigation Links
Kevin Garrity Named President of HollisterStier Allergy
Date:4/26/2011

SPOKANE, Wash. April 26, 2011 /PRNewswire/ -- HollisterStier Allergy announced that they have recently added Kevin Garrity as the president of the business, illustrating the continued investment in the organization by their corporate parent, Jubilant Life Sciences, Ltd (Jubilant).  

(Photo:  http://photos.prnewswire.com/prnh/20110426/SF89673)

Garrity holds over 25 years of healthcare experience, 15 of which involved selling in vitro allergy diagnostic products and services.  Garrity recently held the title of General Manager and Chief Operating Officer for an in vitro diagnostics manufacturer and clinical laboratory service provider dedicated to immune hypersensitivities.  Garrity holds a Bachelor of Science in medical technology and a Master of Business Administration from Texas State University.  

HollisterStier Allergy has recently seen an influx of investment from Jubilant, evidenced by the completion of recent laboratory and production area expansions, the undertaking of research and development projects, and the addition of Garrity to HollisterStier Allergy leadership.

About HollisterStier Allergy

HollisterStier Allergy is a leading manufacturer of high-quality allergy products for the global market.  The organization provides a complete line of products for the testing and treatment of allergies.  HollisterStier Allergy's product portfolio includes many exclusive products, such as the Acetone Precipitated (AP)™ line of extracts and a complete line of skin testing devices including QUINTIP® and ComforTen®.  HollisterStier Allergy is owned by Jubilant Life Sciences, Ltd., and is located in Spokane, Washington.

For more info:  www.hsallergy.com

About Jubilant

Jubilant Life Sciences Limited (formerly Jubilant Organosys Ltd) is an integrated Pharma and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution (DDDS) provider out of India. The Company provides Life Sciences products and services across the value chain. With 10 world-class manufacturing facilities and a team of ~5700 people across the globe, the Company is committed to deliver value to its customers spread across 60 countries. The Company is well recognized as a 'Partner of Choice' by leading life sciences companies worldwide.

For more info: www.jubl.com

MEDIA INQUIRIES:
Alison Marlin
509.951.0165
alison_marlin@hollister-stier.com


'/>"/>
SOURCE HollisterStier Allergy
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Appoints Kevin Bracken Vice President of Manufacturing
2. Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
3. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
4. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
5. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
8. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
9. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
10. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
11. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
Breaking Biology News(10 mins):